Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yuan Peng
CONTACT
Yi-Kun Kang
CONTACT
Lead
Chinese Academy of Medical Sciences
The purpose of this study is: 1. To explore the Response rate (RR) and progression-free survival(PFS) and safety of patients with recurrent metastatic breast cancer who received trastuzumab combined with pyrotinib in positive plasma HER2 amplification detected by digital PCR. 2. To explore the potential using of digital PCR in recurrent and metastatic breast cancer.
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted